International Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . International Biotechnology Trust
IBT Stock   694.00  8.00  1.17%   
International Biotechnology financial statements provide useful quarterly and yearly information to potential International Biotechnology Trust investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on International Biotechnology financial statements helps investors assess International Biotechnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting International Biotechnology's valuation are summarized below:
Gross Profit
-13.6 M
Profit Margin
0.9066
Exchange Market
LSE - MAIN MARKET
Market Capitalization
249.1 M
Enterprise Value Revenue
6.7738
There are over sixty-eight available fundamental trends for International Biotechnology, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of International Biotechnology's regular performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

International Biotechnology Total Revenue

21.11 Million

Check International Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among International Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 1.1 M or Total Revenue of 21.1 M, as well as many indicators such as . International financial statements analysis is a perfect complement when working with International Biotechnology Valuation or Volatility modules.
  
This module can also supplement various International Biotechnology Technical models . Check out the analysis of International Biotechnology Correlation against competitors.

International Biotechnology Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets204.7 M308.2 M263.9 M
Slightly volatile
Total Stockholder Equity193.5 M282.3 M247.5 M
Pretty Stable
Other Liabilities316.4 K333 K1.6 M
Slightly volatile
Other Assets323.6 M308.2 M60.6 M
Slightly volatile
Short Term Investments5.2 M5.4 M11.5 M
Slightly volatile
Total Liabilities27.2 M25.9 M17.4 M
Slightly volatile
Common Stock10.4 M9.3 M11.8 M
Slightly volatile
Accounts Payable1.8 M1.9 M2.1 M
Pretty Stable
Total Current Liabilities156.2 K164.4 K1.9 M
Pretty Stable
Non Current Assets Total210.9 M297.5 M235.7 M
Slightly volatile
Cash And Short Term Investments12.6 M12 M3.8 M
Slightly volatile
Net Receivables94 K99 K3.4 M
Very volatile
Common Stock Total Equity10.4 M9.3 M11.2 M
Slightly volatile
Common Stock Shares Outstanding38 M38.2 M43.1 M
Slightly volatile
Liabilities And Stockholders Equity218.2 M308.2 M244.1 M
Slightly volatile
Non Current Liabilities Total39.2 M37.3 M13.2 M
Slightly volatile
Total Current Assets11.2 M10.6 M5.7 M
Pretty Stable
Short and Long Term Debt Total18.7 M22.8 M15.3 M
Slightly volatile
Accumulated Other Comprehensive Income310.9 M296.1 M122.1 M
Slightly volatile
Net Tangible Assets282.9 M327.6 M257 M
Slightly volatile
Long Term Investments302.4 M297.5 M266.7 M
Slightly volatile
Short and Long Term Debt11.8 M7.4 M7.3 M
Pretty Stable
Short Term Debt19.7 M22.8 M15 M
Slightly volatile
Capital Surpluse23.7 M34.4 M22.6 M
Slightly volatile
Net Invested Capital330.4 M305.1 M285.9 M
Slightly volatile
Capital Stock11.4 M11.9 M10.5 M
Slightly volatile

International Biotechnology Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.1 M1.1 M1.1 M
Slightly volatile
Other Operating Expenses14.9 M14.2 M2.9 M
Slightly volatile
Total Operating Expenses42.1 M40.1 M6.4 M
Slightly volatile
Income Tax Expense97.5 K135 K89.2 K
Slightly volatile
Tax Provision129.3 K135 K114.2 K
Slightly volatile
Research Development0.860.911.542
Pretty Stable

International Biotechnology Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Dividends Paid11.1 M10.8 M9.9 M
Slightly volatile
Change To Netincome3.5 M3.9 M4.3 M
Slightly volatile

International Fundamental Market Drivers

Forward Price Earnings714.2857
Cash And Short Term Investments10.4 M

About International Biotechnology Financial Statements

International Biotechnology stakeholders use historical fundamental indicators, such as International Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although International Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in International Biotechnology's assets and liabilities are reflected in the revenues and expenses on International Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in International Biotechnology Trust. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-29.1 M-27.6 M
Total Revenue40.1 M21.1 M
Cost Of Revenue17 M17.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in International Stock

International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY